Belpointe Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,547
| Closed | -$802K | – | 813 |
|
|
2023
Q1 | $802K | Buy |
11,547
+683
| +6% | +$47.4K | 0.04% | 395 |
|
|
2022
Q4 | $737K | Sell |
10,864
-672
| -6% | -$45.6K | 0.04% | 396 |
|
|
2022
Q3 | $632K | Buy |
11,536
+1,716
| +17% | +$94K | 0.04% | 427 |
|
|
2022
Q2 | $648K | Sell |
9,820
-1,984
| -17% | -$131K | 0.04% | 399 |
|
|
2022
Q1 | $783K | Buy |
11,804
+3,389
| +40% | +$225K | 0.05% | 397 |
|
|
2021
Q4 | $491K | Sell |
8,415
-4,515
| -35% | -$263K | 0.03% | 529 |
|
|
2021
Q3 | $776K | Buy |
12,930
+6,635
| +105% | +$398K | 0.05% | 377 |
|
|
2021
Q2 | $377K | Sell |
6,295
-228
| -3% | -$13.7K | 0.03% | 587 |
|
|
2021
Q1 | $324K | Sell |
6,523
-393
| -6% | -$19.5K | 0.03% | 573 |
|
|
2020
Q4 | $346K | Sell |
6,916
-3,451
| -33% | -$173K | 0.03% | 508 |
|
|
2020
Q3 | $568K | Buy |
10,367
+5,607
| +118% | +$307K | 0.06% | 307 |
|
|
2020
Q2 | $252K | Buy |
4,760
+75
| +2% | +$3.97K | 0.03% | 460 |
|
|
2020
Q1 | $209K | Sell |
4,685
-75
| -2% | -$3.35K | 0.04% | 420 |
|
|
2019
Q4 | $238K | Sell |
4,760
-386
| -8% | -$19.3K | 0.03% | 490 |
|
|
2019
Q3 | $229K | Sell |
5,146
-684
| -12% | -$30.4K | 0.04% | 439 |
|
|
2019
Q2 | $241K | Sell |
5,830
-100
| -2% | -$4.13K | 0.05% | 371 |
|
|
2019
Q1 | $240K | Sell |
5,930
-134
| -2% | -$5.42K | 0.05% | 276 |
|
|
2018
Q4 | $230K | Buy |
6,064
+1,075
| +22% | +$40.8K | 0.06% | 318 |
|
|
2018
Q3 | $197K | Buy |
+4,989
| New | +$197K | 0.03% | 452 |
|
|
2018
Q2 | – | Sell |
-8,350
| Closed | -$292K | – | 340 |
|
|
2018
Q1 | $292K | Sell |
8,350
-2,857
| -25% | -$99.9K | 0.09% | 257 |
|
|
2017
Q4 | $389K | Buy |
11,207
+2,090
| +23% | +$72.5K | 0.09% | 285 |
|
|
2017
Q3 | $309K | Buy |
+9,117
| New | +$309K | 0.07% | 308 |
|